/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Cellebrite DI (CLBT) stopped paying a dividend after 2021 and pays nothing today. The business does generate free cash flow of $160 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
No. Cellebrite DI (CLBT) does not currently pay a dividend. The last payment in our data was in 2021, and nothing has been paid since.
It largely does not. Cellebrite DI pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
On the numbers, yes. Cellebrite DI generated $160 million of free cash flow, which is about $0.64 per share. If it paid out half of that, the dividend would be roughly $0.32 per share, a yield of about 2.0% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Our Technology sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Cellebrite DI.
SourceDividend analysis computed from the 10-K filed 3 Mar 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 5 Jun 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.